Redefining fermentation through innovative service solutions.
Redefining fermentation through innovative service solutions.
Redefining fermentation through innovative service solutions.
More Info
Our Approach
  • Process Analytics
    Process Analytics

    Xylogenics has performed over 6,000 commercial process model analyses. This combined with our unique IT and analytics platform allows us to model commercial fermentation processes with tremendous accuracy and predictability.

  • Synthetic Biology
    Synthetic Biology

    Xylogenics has a combined 100+ years of experience in genetics, metabolic engineering, physiology, and molecular biology, with 75+ years of experience in the yeast, Saccharomyces cerevisiae. This experience is harnessed to design, construct, and validate novel organisms that enable more efficient and productive bio-based chemical synthesis.

  • Commercial Implementation
    Commercial Implementation

    Xylogenics team has rare experience shepherding enhanced yeast through
    the commercial scale-up process.
    This process includes yeast production optimization and commercial scale implementation of novel fermentation systems.

Core Specialties
At Xylogenics, we draw from our vast experience in genetics, molecular biology, and fermentation to deliver value added services and products that create exceptional value for our customers.
More Info
Small Scale Fermentation Process Modeling
Small Scale Fermentation Process Modeling
Yeast Genetics & Cell Biology
Yeast Genetics & Cell Biology
Custom Yeast Design & Commercialization
Custom Yeast Design & Commercialization
Enzyme & Fermentation Expertise
Enzyme & Fermentation Expertise
Xylogenics Team

Our team is made up of home brewers, thinkers, innovators, farmers, scientists, problem solvers, and business development leaders. These traits of the Xylogenics team are intensely focused on delivering product innovations that are safe, scalable, and highly valuable to bio-based chemical producers.

News / Articles
Study Finds Mylan’s ‘Biosimilar’ Drug Comparable to Roche Cancer Medicine

CHICAGO—Researchers said a drug being developed by Mylan Pharmaceuticals Inc. proved comparable to Roche Holding AG’s Herceptin in a clinical trial, a …

2016 National Advanced Biofuels Conference wraps in Milwaukee

The 2016 National Advanced Biofuels Conference & Expo took place in Milwaukee, Wisconsin, this week, hosting a number of panels …